Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Perry ME et al. - Etanercept represents a useful alternative to immunosuppressant therapy such as cyclophosphamide or chlorambucil. However, further work is needed to establish whether organ damage related to AA amyloidosis is slowed by etanercept.

Methods

Results

Today in Clinical Pharmacology...keeping you current

Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis
Rheumatology International, 12/15/09

First-line DMARD choice in early rheumatoid arthritis - Do prognostic factors play a role?
Rheumatology, 12/15/09

Use of oral bisphosphonates and risk of venous thromboembolism: A population-based case-control study
Osteoporosis International, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address